Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | CRHBP | P24387 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.50 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.50 |
| ▸ | APP | P05067 | 2/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6013505 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4 | |
| SCHEMBL101594 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4 | |
| SCHEMBL13020777 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4 | |
| SCHEMBL8644338 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4 | |
| SCHEMBL12593200 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4 | |
| SCHEMBL2070021 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4 | |
| SCHEMBL879258 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4 | |
| SCHEMBL12780851 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4 | |
| Benzene SCHEMBL14537408 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4 | |
| SCHEMBL14018359 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 442 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1182183-B1 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICES MADE BY USING THE SAME | IDEMITSU KOSAN CO (JP) | 2009-12-09 | — | — | EP | claimed |
| EP-4396259-A1 | COMPOSITION | Merck Patent GmbH (DE) | 2024-07-10 | — | — | EP | disclosed |
| WO-2024126635-A1 | FORMULATION OF AN ORGANIC FUNCTIONAL MATERIAL | MERCK PATENT GMBH (DE) | 2024-06-20 | — | — | WO | disclosed |
| WO-2023237458-A1 | METHOD OF PRINTING A FUNCTIONAL LAYER OF AN ELECTRONIC DEVICE BY COMBINING INKS | MERCK PATENT GMBH (DE) | 2023-12-14 | — | — | WO | disclosed |
| EP-3475372-B1 | FORMULATION OF AN ORGANIC FUNCTIONAL MATERIAL | MERCK PATENT GMBH (DE) | 2023-11-22 | — | — | EP | disclosed |
| EP-3387077-B1 | FORMULATIONS CONTAINING KETONES COMPRISING NON-AROMATIC CYCLES | MERCK PATENT GMBH (DE) | 2023-10-18 | — | — | EP | disclosed |
| US-11770971-B2 | Esters containing aromatic groups as solvents for organic electronic formulations | MERCK PATENT GMBH (DE) | 2023-09-26 | — | — | US | disclosed |
| EP-3807367-B1 | FORMULATION OF AN ORGANIC FUNCTIONAL MATERIAL | MERCK PATENT GMBH (DE) | 2023-07-19 | — | — | EP | disclosed |
| EP-3552252-B1 | PREPARATION PROCESS FOR AN ELECTRONIC DEVICE | MERCK PATENT GMBH (DE) | 2023-05-17 | — | — | EP | disclosed |
| EP-3360175-B1 | FORMULATIONS COMPRISING AT LEAST TWO ORGANIC SEMICONDUCTING COMPOUNDS AND AT LEAST TWO SOLVENTS | MERCK PATENT GMBH (DE) | 2023-05-17 | — | — | EP | disclosed |
| US-20040100188-A1 | Anthracene derivative and organic electroluminescence device using the derivative | IDEMITSU KOSAN CO., LTD. (JP) | 2004-05-27 | — | — | US | disclosed |
| US-6660410-B2 | Organic luminescence layer having a carbazole derivative with a glass-transition temperature of 110 degrees C. or higher, and a phosphorescent dopant; possible triplet exciton state at room temperature | IDEMITSU KOSAN CO., LTD. (JP) | 2003-12-09 | — | — | US | disclosed |
| US-20020168544-A1 | Organic electroluminescence device emitting white light | IDEMITSU KOSAN CO., LTD. (JP) | 2002-11-14 | — | — | US | disclosed |
| EP-1205527-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2002-05-15 | — | — | EP | disclosed |
| US-20020048687-A1 | Anthracene derivative and organic electroluminescence device using the derivative | IDEMITSU KOSAN CO., LTD. (JP) | 2002-04-25 | — | — | US | disclosed |
| US-20020045061-A1 | Organic luminescence layer having a carbazole derivative with a glass-transition temperature of 110 degrees C. or higher, and a phosphorescent dopant; possible triplet exciton state at room temperature | IDEMITSU KOSAN CO., LTD. | 2002-04-18 | — | — | US | disclosed |
| EP-1182244-A1 | WHITE ORGANIC ELECTROLUMINESCENCE ELEMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2002-02-27 | — | — | EP | disclosed |
| EP-1182183-A1 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICES MADE BY USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2002-02-27 | — | — | EP | disclosed |
| EP-0420092-A1 | Process for the preparation of 1-hydroxy-imidazole | BASF Aktiengesellschaft (DE) | 1991-04-03 | — | — | EP | disclosed |
| EP-0420092-A1 | Process for the preparation of 1-hydroxy-imidazole | BASF Aktiengesellschaft (DE) | 1991-04-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040100188-A1 | Anthracene derivative and organic electroluminescence device using the derivative | ACIN1, KCNQ1, LBR | ALDH1A1 200/4885TDP1 1727/4885L3MBTL1 323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.